Stimulation of monocyte cGMP by leukocyte dialysates. An antigen-independent property of dialyzable transfer factor.
Open Access
- 1 November 1975
- journal article
- research article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 56 (5) , 1271-1279
- https://doi.org/10.1172/jci108203
Abstract
We studied the effects of dialysates from leukocyte lysates containing dialyzable transfer factor activity and other leukocyte dialysates devoid of transfer factor activity on accumulation of cyclic nucleotides in human leukocytes. Dialysates from normal leukocytes produced 4- to 11-fold increases in leukocyte cGMP, and experiments with purified cell populations revealed that the increases were predominantly, if not entirely, in blood monocytes. Substances that increased monocyte cGMP could be obtained from several cell populations including mononuclear cells from Hypaque-Ficoll gradients, plastic-adherent monocytes, nonadherent lymphocytes, and neutrophils, but were not present in dialysates of leukemic lymphocytes from patients with the Sezary syndrome. Moreover, dialysates that increased leukocyte cGMP had essentially no effect on intracellular cAMP. Dialysates of lysed mononuclear cells contained serotonin, ascorbate, and an unidentified cholinergic activity, agents known to increase leukocyte cGMP. After passage of dialyzable transfer factor from mononuclear cells through a gel-filtration column, four fractions were obtained that increased leukocyte cGMP. Two of these fractions contained ascorbate; two other active fractions, including one that also caused conversion of delayed skin tests, did not contain detectable ascorbate or serotonin. The dialysate of lysed neutrophils also increased cGMP, but this activity was limited to the column fractions which contained ascorbic acid. These observations raise the possibility that alterations in monocyte cGMP content could modulate either the specific antigen-dependent, or, more likely, the antigen-independent activities in preparations of transfer factor.This publication has 33 references indexed in Scilit:
- Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.Journal of Clinical Investigation, 1975
- The effect of serotonin (5-hydroxytryptamine) and derivatives on guanosine 3',5'-monophosphate in human monocytes.Journal of Clinical Investigation, 1975
- Effects of Cholera Toxin on In Vitro Models of Immediate and Delayed Hypersensitivity. FURTHER EVIDENCE FOR THE ROLE OF CYCLIC ADENOSINE 3′,5′-MONOPHOSPHATEJournal of Clinical Investigation, 1973
- Effect of transfer factor on lymphocyte function in anergic patientsJournal of Clinical Investigation, 1972
- IMMUNOLOGICAL RELEASE OF HISTAMINE AND SLOW REACTING SUBSTANCE OF ANAPHYLAXIS FROM HUMAN LUNGThe Journal of Experimental Medicine, 1972
- Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3',5'-adenosine monophosphate.1971
- MULTIPLE PASSIVE TRANSFER OF DELAYED TYPE OF HYPERSENSITIVITY IN HUMANSPublished by Elsevier ,1962
- IMMUNOLOGIC STUDIES WITH ETHYLENE OXIDE-TREATED HUMAN SERUMThe Journal of Experimental Medicine, 1961
- Transfer of Delayed Hypersensitivity to Coccidioidin in ManThe Journal of Immunology, 1960
- TRANSFER OF DELAYED HYPERSENSITIVITY TO SKIN HOMOGRAFTS WITH LEUKOCYTE EXTRACTS IN MAN*Journal of Clinical Investigation, 1960